APREA THERAPEUTICS INC's ticker is APRE and the CUSIP is 03836J102. A total of 41 filers reported holding APREA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 3.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -61.3% | 16,643 | -0.4% | 0.00% | – |
| Q1 2022 | $31,000 | -35.4% | 16,703 | -0.8% | 0.00% | – |
| Q4 2021 | $48,000 | -44.2% | 16,843 | 0.0% | 0.00% | – |
| Q3 2021 | $86,000 | +3.6% | 16,843 | 0.0% | 0.00% | – |
| Q2 2021 | $83,000 | -66.0% | 16,843 | -64.8% | 0.00% | – |
| Q1 2021 | $244,000 | +63.8% | 47,783 | +57.5% | 0.00% | – |
| Q4 2020 | $149,000 | -78.3% | 30,336 | +6.4% | 0.00% | – |
| Q3 2020 | $686,000 | -33.2% | 28,511 | +7.7% | 0.00% | – |
| Q2 2020 | $1,027,000 | -22.1% | 26,477 | -30.2% | 0.00% | – |
| Q1 2020 | $1,318,000 | +73.4% | 37,953 | +129.1% | 0.00% | – |
| Q4 2019 | $760,000 | – | 16,567 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 1,259,662 | $6,437,000 | 2.66% |
| COASTAL INVESTMENT MANAGEMENT, L.P. | 41,965 | $214,000 | 0.30% |
| Redmile Group, LLC | 694,918 | $3,551,000 | 0.06% |
| Quantamental Technologies LLC | 13,752 | $70,000 | 0.05% |
| KENNEDY CAPITAL MANAGEMENT LLC | 342,486 | $1,750,000 | 0.04% |
| PDT Partners, LLC | 87,734 | $448,000 | 0.03% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,000 | $383,000 | 0.01% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 49,100 | $251,000 | 0.01% |
| NEXT Financial Group, Inc | 11,347 | $58,000 | 0.01% |
| Sugarloaf Wealth Management, LLC | 1,500 | $8,000 | 0.00% |